P

Inventor

GEORGIOU GEORGE

US85 patents
⚠️ This page may combine multiple inventors who share the name “GEORGIOU GEORGE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV TEXAS

23 patents
US5866344AFeb 2, 1999

Antibody selection methods using cell surface expressed libraries

UNIV TEXAS142 citations99
US6083715AJul 4, 2000

Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells

UNIV TEXAS295 citations97
US6027888AFeb 22, 2000

Methods for producing soluble, biologically-active disulfide-bond containing eukaryotic proteins in bacterial cells

UNIV TEXAS288 citations97
US5508192AApr 16, 1996

Bacterial host strains for producing proteolytically sensitive polypeptides

UNIV TEXAS322 citations97
US5264365ANov 23, 1993

Protease-deficient bacterial strains for production of proteolytically sensitive polypeptides

UNIV TEXAS303 citations97
US9808486B2Nov 7, 2017

Administration of kynurenine depleting enzymes for tumor therapy

UNIV TEXAS17 citations92
US9481877B2Nov 1, 2016

Engineered primate L-methioninase for therapeutic purposes

UNIV TEXAS14 citations92
US7611866B2Nov 3, 2009

Selection of bacterial inner-membrane anchor polypeptides

UNIV TEXAS20 citations91
US7094571B2Aug 22, 2006

Combinatorial protein library screening by periplasmic expression

UNIV TEXAS50 citations91
US7083945B1Aug 1, 2006

Isolation of binding proteins with high affinity to ligands

UNIV TEXAS26 citations91
US6916474B2Jul 12, 2005

Antibodies with increased affinities for anthrax antigens

UNIV TEXAS22 citations91
US5316940AMay 31, 1994

Constitutive soluble methane monooxygenase mutants of methanotrophic bacteria such as Methylosinus trichosporium A.T.C.C. 55314

UNIV TEXAS53 citations90
US9708654B2Jul 18, 2017

High throughput sequencing of multiple transcripts

UNIV TEXAS37 citations87
US10772913B2Sep 15, 2020

Administration of kynurenine depleting enzymes for tumor therapy

UNIV TEXAS5 citations84
US10363311B2Jul 30, 2019

Engineered primate cystine/cysteine degrading enzymes as antineogenic agents

UNIV TEXAS4 citations84
US10233438B2Mar 19, 2019

Engineered primate L-methioninase for therapeutic purposes

UNIV TEXAS6 citations83
US9975959B2May 22, 2018

Administration of kynurenine depleting enzymes for tumor therapy

UNIV TEXAS8 citations83
US9624484B2Apr 18, 2017

Engineered primate L-methioninase for therapeutic purposes

UNIV TEXAS11 citations83
US9146241B2Sep 29, 2015

Proteomic identification of antibodies

UNIV TEXAS9 citations78
US11534463B2Dec 27, 2022

Nucleic acids encoding kynurenine depleting enzymes

UNIV TEXAS1 citations73
US10716856B2Jul 21, 2020

Engineered primate cystine/cysteine degrading enzymes as antineogenic agents

UNIV TEXAS2 citations73
US11168142B2Nov 9, 2021

Administration of kynurenine depleting enzymes for tumor therapy

UNIV TEXAS5 citations72
US10724026B2Jul 28, 2020

Engineered primate L-methioninase for therapeutic purposes

UNIV TEXAS2 citations72

GEORGIOU GEORGE

9 patents

RES DEV FOUNDATION

3 patents

AEMASE INC

2 patents

MCI COMMUNICATIONS CORP

2 patents

RES FOUND DEV

2 patents

AERASE INC

2 patents

THERASENSE INC

1 patent

HARVARD COLLEGE

1 patent

AMAZON TECH INC

1 patent

LUCENT TECHNOLOGIES INC

1 patent

MANGAL MANISH

1 patent

REDDY SAI

1 patent

REGENTS THE UNIVERSIRY OF TEXA

1 patent

Showing the top 50 of 85 patents by PatentIndex Score.